Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine the preliminary anti-tumour activity of AZD2171 (45 mg/day) in GIST patients by assessment with FDG-PET following 8 days and 4 weeks of dosing (central review of SUVmax).
Inclusion criteria
- Metastatic Gastro-Intestinal Stromal Tumours